Selecting the right treatment plan for schizophrenia in postmenopausal women: an update of the literature

References

• SeemanMV, CohenR. Focus on women: aservice for women with schizophrenia. Psychiatr Serv. 1998;49(5):674–677.
   PubMedGoogle Scholar
• CulbertKM, ThakkarKN, KlumpKL. Risk for midlife psychosis in women: critical gaps and opportunities in exploring perimenopause and ovarian hormones as mechanisms of risk. Psychol Med. 2022;52(9):1612–1620.
   PubMed Web of Science ®Google Scholar
• JohnstoneS, Dela CruzA, GirardT, etal. Potential explanatory models of the female preponderance in very late onset schizophrenia. Women. 2022;2(4):353–370.
   Google Scholar
• González-RodríguezA, GuàrdiaA, MonrealJA. Peri- and post-menopausal women with schizophrenia and related disorders are apopulation with specific needs: anarrative review of current theories. JPerson Med. 2021:11(9):849. DOI:10.3390/jpm11090849
   PubMedGoogle Scholar
• SeemanMV, GuptaR. BLINDED selective review of age-related needs of women with schizophrenia. Clin Schizophr Relat Psychoses. 2015;9(1):21–29.
   PubMedGoogle Scholar
• ChienWT, LeungSF, YeungFKK, etal. Current approaches to treatments for schizophrenia spectrum disorders, part II: psychosocial interventions and patient-focused perspectives in psychiatric care. Neuropsychiatr Dis Treat. 2013;9:1463–1481.
   PubMed Web of Science ®Google Scholar
• MorinL, FranckN. Rehabilitation interventions to promote recovery from schizophrenia: asystematic review. Front Psychiatry. 2017;8. DOI:10.3389/fpsyt.2017.00100
   PubMed Web of Science ®Google Scholar
• SterkB, van RossumIW, MuisM, etal. Priorities, satisfaction and treatment goals in psychosis patients: an online consumer’s survey. Pharmacopsychiatry. 2013;46(03):88–93.
   PubMedGoogle Scholar
• BrzezinskiA, Brzezinski-SinaiNA, SeemanMV. Treating schizophrenia during menopause. Menopause. 2017;24(5):582–588.
   PubMed Web of Science ®Google Scholar
• Brzezinski-SinaiN, BrzezinskiA. Schizophrenia and sex hormones: what is the link? Front Psychiatry. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• StuartH. Mental illness and employment discrimination. Curr Opin Psychiatry. 2006:19(5):522–526. DOI:10.1097/01.yco.0000238482.27270.5d
   PubMed Web of Science ®Google Scholar
• WalkerH, GrantD, MeadowsM, etal. Women’s experiences and perceptions of age discrimination in employment: implications for research and policy. Soc Policy Societ. 2007;6(1):37–48.
   Google Scholar
• AraiY, SasayamaD, KuraishiK, etal. Analysis of the effect of brexpiprazole on sleep architecture in patients with schizophrenia: apreliminary study. Neuropsychopharmacol Rep. 2023;43(1):112–119.
   PubMed Web of Science ®Google Scholar
• CederlöfE, HolmM, LähteenvuoM, etal. Sleep in psychotic disorders: results from nationwide SUPER Finland study. Schizophr Bull Open. 2022;3(1):sgac011.
   Google Scholar
• CederlöfE, HolmM, AhtiJ, etal. Substance use and sleep problems in patients with psychotic disorders. Schizophr Bull Open. 2023;4(1):sgac073.
   Google Scholar
• MontiJM, TorteroloP, Pandi PerumalSR. The effects ofsecond generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia. Sleep Med Rev. 2017;33:51–57. DOI:10.1016/j.smrv.2016.05.002
   PubMed Web of Science ®Google Scholar
• ChopraA, PatelRS, BaligaN, etal. Sleepwalking and sleep-related eating associated with atypical antipsychotic medications: case series and systematic review of literature. Gen Hosp Psychiatry. 2020;65:74–81.
   PubMed Web of Science ®Google Scholar
• SeemanMV, Sleepwalking. Apossible side effect of antipsychotic medication. Psychiatr Q. 2011;82(1):59–67. DOI:10.1007/s11126-010-9149-8
   PubMed Web of Science ®Google Scholar
• UlanderM, RangtellF, Theorell-HaglowJ. Sleep measurements in women. Sleep Med Clin. 2021;16(4):635–648.
   PubMed Web of Science ®Google Scholar
• KhazaieH, MazharS, MoghadamAP, etal. Effect of atypical antipsychotic medications on the risk of obstructive sleep apnea in individuals with schizophrenia. Sleep Med Res. 2022;13(2):75–80.
   Google Scholar
• SeemanMV. Diagnosis and treatment of sleep apnoea in women with schizophrenia. JMent Health. 2014;23(4):191–196.
   PubMed Web of Science ®Google Scholar
• ZolfaghariS, YaoC, ThompsonC, etal. Effects of menopause on sleep quality and sleep disorders: Canadian longitudinal study on aging. Menopause. 2020;27(3):295–304.
   PubMed Web of Science ®Google Scholar
• González-RodríguezA, Haba-RubioJ, UsallJ, etal. Hormone targets for the treatment of sleep disorders in postmenopausal women with schizophrenia: anarrative review. Clocks Sleep. 2022;4:52–65.
   PubMedGoogle Scholar
• MosconiL, BertiV, DykeJ, etal. Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition. Sci Rep. 2021;11(1):10867.
   PubMed Web of Science ®Google Scholar
• IqbalJ, TanZN, LiMX, etal. Estradiol alters hippocampal gene expression during the estrous cycle. Endocr Res. 2020;45(2):84–101. DOI:10.1080/07435800.2019.1674868
   PubMed Web of Science ®Google Scholar
• Tecalco‑cruzAC, López‑canovasL, Azuara‑liceagaE. Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer’s disease in aging women. Metab Brain Dis. 2023;38:783–793.
   PubMedGoogle Scholar
• McCarthyM, RavalAP. The peri-menopause in awoman’s life: asystemic inflammatory phase that enables later neurodegenerative disease. JNeuroinflammation. 2020:17(1):317. DOI:10.1186/s12974-020-01998-9
   PubMed Web of Science ®Google Scholar
• ChakrabartiM, DasA, SamantarayS, etal. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016;27(3):271–281.
   PubMed Web of Science ®Google Scholar
• Abo-YoussefAM, KhallafWA, KhattabMM, etal. The anti-Alzheimer effect of telmisartan in ahyperglycemic ovariectomized rat model; role of central angiotensin and estrogen receptors. Food Chem Toxicol. 2020;142:111441.
   PubMed Web of Science ®Google Scholar
• LejeuneJA, NorthropA, KurtzMM. A meta-analysis of cognitive remediation for schizophrenia: efficacy and the role of participant and treatment factors. Schizophr Bull. 2021:47(4):997–1006. DOI:10.1093/schbul/sbab022
   PubMed Web of Science ®Google Scholar
• FalkaiP, SchmittA. The need to develop personalized interventions to improve cognition in schizophrenia. World Psychiatry. 2019;18:170.
   PubMed Web of Science ®Google Scholar
• De LangeAH, Van der HeijdenB, Van VuurenT, etal. Employable as we age? Asystematic review of relationships between age conceptualizations and employability. Front Psychol. 2020;11:11.
   PubMed Web of Science ®Google Scholar
• BouwmansC, de SonnevilleC, MulderCL, etal. Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatr Dis Treat. 2015;11:2125–2142.
   PubMed Web of Science ®Google Scholar
• MueserKT, DrakeE, BondGR. Recent advances in supported employment for people with serious mental illness. Curr Opin Psychiatry. 2016;29(3):196–201.
   PubMed Web of Science ®Google Scholar
• TepavicharovNK, ChristensenJR, MøllerT, etal. “Moving on to an open world”: astudy of participants’ experience in Meaningful Activities and Recovery (MA&R). Occupat Therapy Int. Article ID 7418667 2022l;2022:1–12.
   Web of Science ®Google Scholar
• HjorthojC, SturupAE, McGrathJJ, etal. Years of potential life lost and life expectancy in schizophrenia: asystematic review and meta-analysis. Lancet Psychiatry. 2017:4;295–301. DOI:10.1016/S2215-0366(17)30078-0
   PubMed Web of Science ®Google Scholar
• AliS, SantomauroD, FerrariAJ, etal. Schizophrenia as arisk factor for cardiovascular and metabolic health outcomes: acomparative risk assessment. Epidemiol Psychiatr Sci. 2021;32(e8):1–8.
   Google Scholar
• ChanJKN, WongCSM, PCFO, etal. Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population based cohort study. Br JPsychiatry. 2021;219:375–382.
   PubMed Web of Science ®Google Scholar
• ReynoldsG, KirkS. Metabolic side effects of antipsychotic drug treatment– pharmacological mechanisms. Pharmacol Ther. 2010;125:169–179. DOI:10.1016/j.pharmthera.2009.10.010
   PubMed Web of Science ®Google Scholar
• PereiraS, AuE, AgarwalSM, etal. Antipsychotic-induced alterations in lipid turnover. Endocrinology. 2023;164(4).
   PubMed Web of Science ®Google Scholar
• HoltRIG. Association between antipsychotic medication use and diabetes. Curr Diab Rep. 2019;19:96.
   PubMed Web of Science ®Google Scholar
• GoodE, BhattacharyaD, ScottS. What is known about the determinants of developing antipsychotic-induced metabolic syndrome and interventions to address them for community dwelling adults: ascoping review protocol. Psychiatry Clin Psychol. 2023 Jan 8. DOI:10.1101/2023.01.05.22283663
   Google Scholar
• ChristakisMK, HaroonH, De SouzaLR, etal. The effect of menopause on metabolic syndrome: cross-sectional results from the Canadian longitudinal study on aging. Menopause. 2020;27(9):999–1009.
   PubMed Web of Science ®Google Scholar
• TanA, ThomasRL, CampbellMD, etal. Effects of exercise training on metabolic syndrome risk factors in post-menopausal women– asystematic review and meta-analysis of randomised controlled trials. Clin Nutr. 2023;42(3):337–351. DOI:10.1016/j.clnu.2023.01.008
   PubMed Web of Science ®Google Scholar
• ChengC-H, ChenL-R, ChenK-H. Osteoporosis due to hormone imbalance: an overview of the effects of estrogen deficiency and glucocorticoid overuse on bone turnover. IntJMol Sci. 2022;23(3):1376.
   Google Scholar
• AndradeC. Prolactin-raising and prolactin-sparing antipsychotic drugs and the risk of fracture and fragility fracture in patients with schizophrenia, dementia, and other disorders. JClin Psychiatry. 2023;84(1):23f14790.
   PubMedGoogle Scholar
• LiangY, HuangJ, TianJ-B, etal. Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia. Clin Intervent Aging. 2016;11:153–157.
   PubMed Web of Science ®Google Scholar
• KanisJA, CooperC, RizzoliR, etal. Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Calcif Tissue Int. 2019:104;235–238. DOI:10.1007/s00223-018-00512-x
   PubMed Web of Science ®Google Scholar
• WlukaAE, CicuttiniFM, TimD, etal. Menopause, oestrogens and arthritis. Maturitas. 2000;35(3):183–199.
   PubMed Web of Science ®Google Scholar
• SeemanMV. Preventing breast cancer in women with schizophrenia. Acta Psychiatr Scand. 2011;123(2):107–117. DOI:10.1111/j.1600-0447.2010.01626.x
   PubMed Web of Science ®Google Scholar
• García-EstévezL, CortésJ, PérezS, etal. Obesity and breast cancer: aparadoxical and controversial relationship influenced by menopausal status. Front Oncol. 2021;11:11.
   Web of Science ®Google Scholar
• LuD, SongJ, LuY, etal. Ashared genetic contribution to breast cancer and schizophrenia. Nat Commun. 2020:11;4637. DOI:10.1038/s41467-020-18492-8
   PubMed Web of Science ®Google Scholar
• MoiseN, WainbergM, ShahRN. Primary care and mental health: where do we go from here? World JPsychiatry. 2021:11(7):271–276. DOI:10.5498/wjp.v11.i7.271
   PubMed Web of Science ®Google Scholar
• BrandB, HavemanY, De BeerF, etal. Antipsychotic medication for women with schizophrenia spectrum disorders. Psychol Med. 2022;52(4):649–663. DOI:10.1017/S0033291721004591
   PubMed Web of Science ®Google Scholar
• HooperSC, MarshallVB, BeckerCB, etal. Mental health and quality of life in postmenopausal women as afunction of retrospective menopause symptom severity. Menopause. 2022;29(6):707–713. DOI:10.1097/GME.0000000000001961
   PubMed Web of Science ®Google Scholar
• HuLY, ShenCC, HungJH, etal. Risk of psychiatric disorders following symptomatic menopausal transition: anationwide population-based retrospective cohort study. Medicine (Baltimore). 2016;95:e2800.
   PubMed Web of Science ®Google Scholar
• KundakovicM, RocksD. Sex hormone fluctuation and increased female risk for depression and anxiety disorders: from clinical evidence to molecular mechanisms. Front Neuroendocrinol. 2022;66:66.101010.
   PubMed Web of Science ®Google Scholar
• ThompsonKA, Bardone-ConeAM. Menopausal status and disordered eating and body image concerns among middle-aged women. IntJEating Dis. 2019;52(3):314–318.
   PubMed Web of Science ®Google Scholar
• AbdallaMMI, AzzaniM, AtrooshW, etal. The association between mental health and obesity in postmenopausal women: asystematic review. Endocr Regul. 2022 20;56(4):295–310. DOI:10.2478/enr-2022-0032.
   PubMedGoogle Scholar
• SimbarM, NazarpourS, Alavi MajdH, etal. Is body image apredictor of women’s depression and anxiety in postmenopausal women? BMC Psychiatry. 2020;202. DOI:10.1186/s12888-020-02617-w
   Google Scholar
• WilliJ, EhlertU. Assessment of perimenopausal depression: a review. JAffect Disord. 2019;249:216–222.
   PubMed Web of Science ®Google Scholar
• DotlicJ, RadovanovicS, RancicB, etal. Mental health aspect of quality of life in the menopausal transition. JPsychosom Obstet Gynecol. 2021;42(1):40–49.
   PubMed Web of Science ®Google Scholar
• PalumboC, VolpeU, MatanovA, etal. Social networks of patients with psychosis: asystematic review. BMC Res Notes. 2015;8:560.
   PubMedGoogle Scholar
• SivakumarT, JainJ, PhilipS, etal. Future care planning: concerns of elderly parents caring for aperson with serious mental illness. Psychiatr Serv. 2022;73:96–99.
   PubMed Web of Science ®Google Scholar
• Yoshioka-MaedaK, FujiiH, KageyamaM, etal. Factors of parental preparation of children with mental illnesses for their independent living after their own death. Healthcare (Basel). 2022;10(12):2360. DOI:10.3390/healthcare10122360
   PubMedGoogle Scholar
• ChenF-P. Assisting adults with severe mental illness in transitioning from parental homes to independent living. Community Ment Health J. 2010;46(4):372–380.
   PubMed Web of Science ®Google Scholar
• UsallJ, Pinto-MezaA, FernándezA, etal. Suicide ideation across reproductive life cycle of women. Results from aEuropean epidemiological study. JAffect Disord. 2009;116(1–2):144–147.
   PubMed Web of Science ®Google Scholar
• Baca-GarciaE, Diaz-SastreC, CeverinoA, etal. Suicide attempts among women during low estradiol/low progesterone states. JPsychiatr Res. 2010;44(4):209–214.
   PubMed Web of Science ®Google Scholar
• BogaertAF, BrottoLA. Object of desire self-consciousness theory. JSex Marital Therapy. 2014;40(4):323–338.
   PubMed Web of Science ®Google Scholar
• MernoneL, FiaccoS, EhlertU. Positive body perception and its link to sexual satisfaction in aging women - findings from the women 40+ healthy aging study. JWomen Aging. 2021;35(2):152–167.
   PubMed Web of Science ®Google Scholar
• Dąbrowska-GalasM, DąbrowskaJ, MichalskiB. Sexual dysfunction in menopausal women. Sex Med. 2019;7(4):472–479.
   PubMed Web of Science ®Google Scholar
• DumontaudM, KorchiaT, KhouaniJ, etal. Sexual dysfunctions in schizophrenia: beyond antipsychotics. Asystematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2020;98:109804.
   PubMed Web of Science ®Google Scholar
• RahmaniA, AfsharniaE, FedotovaJ, etal. Sexual function and mood disorders among menopausal women: asystematic scoping review. JSex Med. 2022;19(7):1098–1115.
   Google Scholar
• BrottoL, AtallahS, Johnson-AgbakwuC, etal. Psychological and interpersonal dimensions of sexual function and dysfunction. JSex Med. 2016;13(4):538–571.
   Google Scholar
• BrandBA, de BoerJN, DazzanP, etal. Towards better care for women with schizophrenia-spectrum disorders. JPsychosex Health. 2020;2(1):44–55.
   Google Scholar
• LodhaP, De SousaA. Female sexual dysfunction and schizophrenia: aclinical review. JPsychosex Health. 2020;2(1):44–55.
   Google Scholar
• JayasenaCN, AlkaabiFM, LiebersCS, etal. Asystematic review of randomized controlled trials investigating the efficacy and safety of testosterone therapy for female sexual dysfunction in postmenopausal women. Clin Endocrinol. 2019;90:391–414.
   PubMed Web of Science ®Google Scholar
• SommerIE, BrandBA, GangadinS, etal. Women with schizophrenia-spectrum disorders after menopause: avulnerable group for relapse. Schizophr Bull. 2023;49(1):136–143.
   PubMed Web of Science ®Google Scholar
• KulkarniJ, ButlerS, Riecher-RösslerA. Estrogens and SERMS as adjunctive treatments for schizophrenia. Front Neuroendocrinol. 2019;53:100743.
   PubMed Web of Science ®Google Scholar
• González-RodríguezA, MonrealJA, SeemanMV. The effect of menopause on antipsychotic response. Brain Sci. 2022;12:1342.
   PubMed Web of Science ®Google Scholar
• HoekstraS, Bartz-JohannessenC, SinkeviciuteI, etal. Sex differences in antipsychotic efficacy and side effects in schizophrenia spectrum disorder: results from the BeSt InTro study. NPJ Schizophr. 2021;7(1):39.
   PubMed Web of Science ®Google Scholar
• LiuY, YuanY, DayAJ, etal. Safety and efficacy of compounded bioidentical hormone therapy (cBHT) in perimenopausal and postmenopausal women: asystematic review and meta-analysis of randomized controlled trials. Menopause. 2022;29(4):465–482. DOI:10.1097/GME.0000000000001937
   PubMed Web of Science ®Google Scholar
• CitromeL, IsaacsonSH, LarsonD, etal. Tardive dyskinesia in older persons taking antipsychotics. Neuropsychiatr Dis Treat. 2021;17:3127–3134.
   PubMed Web of Science ®Google Scholar
• TurroneP, SeemanMV, SilvestriS. Estrogen receptor activation and tardive dyskinesia. Can JPsychiatry. 2000;45(3):288–290.
   PubMed Web of Science ®Google Scholar
• SolmiM, PigatoG, KaneJM, etal. Clinical risk factors for the development of tardive dyskinesia. JNeurol Sci. 2018;389:21–27.
   PubMed Web of Science ®Google Scholar
• TaylorD, WatanabeK. Tardive dyskinesia: understanding current challenges in diagnosis and treatment. Ther Adv Psychopharmacol. 2023;13:204512532211443.
   Google Scholar
• SajatovicM, AlexopoulosG, RoqueA, etal. Improvements over time with long-term valbenazine in older and elderly patients with tardive dyskinesia. Am JGeriatric Psychiatry. 2023;31(3):S126–127.
   Web of Science ®Google Scholar
• Batalla-MartínD, Belzunegui-ErasoA, GarijoM, etal. Insomnia in schizophrenia patients: prevalence and quality of life. IntJEnviron Res Public Health. 2020;17:1350.
   Web of Science ®Google Scholar
• CorberaS, WexlerBE, PoltorakA, etal. Cognitive remediation for adults with schizophrenia: does age matter? Psychiatry Res. 2017;247:21–27.
   PubMed Web of Science ®Google Scholar
• GregoryA, MallikarjunP, UpthegroveR. Treatment of depression in schizophrenia: systematic review and meta-analysis. Br JPsychiatry. 2017;211(4):198–204.
   PubMed Web of Science ®Google Scholar
• BarkerLC, VigodSN. Sexual health of women with schizophrenia: a review. Front Neuroendocrinol. 2020;57:100840.
   PubMed Web of Science ®Google Scholar
• MitchellA, PereiraI, YadegarfarM, etal. Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake. Br JPsychiatry. 2014;205(6):428–435.
   PubMed Web of Science ®Google Scholar
• ChronisterJ, FitzgeraldS, ChouC-C. The meaning of social support for persons with serious mental illness: afamily member perspective. Rehabil Psychol. 2021;66(1):87–101.
   PubMed Web of Science ®Google Scholar
• KirshB, MartinL, HultqvistJ, etal. Occupational therapy interventions in mental health: aliterature review in search of evidence. Occupat Therapy Ment Health. 2019;35(2):109–156.
   Web of Science ®Google Scholar
• SeemanMV. Psychosis and Physical Comorbidity. In: ChandraP, HerrmanH, FisherJ, and Riecher-RösslerA, editors. Mental health and illness of women. Singapore: Springer; 2019. p. 1–28. DOI:10.1007/978-981-10-0371-4_20-1
   Google Scholar
• ThomasAJ, MitchellES, WoodsNF. The challenges of midlife women: themes from the Seattle midlife women’s health study. Womens Midlife Health. 2018;4(8):1–10.
   PubMedGoogle Scholar
• BeckerJB, ChartoffE. Sex differences in neural mechanisms mediating reward and addiction. Neuropsychopharmacol. 2019;44:166–183.
   PubMed Web of Science ®Google Scholar
• TavaresVDO, RossellSL, SchuchFB, etal. Effects of exercise on cognitive functioning in adults with serious mental illness: ameta analytic review. Psychiatry Res. 2023;321:115081.
   PubMed Web of Science ®Google Scholar
• MacdonaldA, AdamisD, CraigT, etal. Continuity of care and clinical outcomes in the community for people with severe mental illness. Br JPsychiatry. 2019;214(5):273–278.
   PubMed Web of Science ®Google Scholar
• ZuckerI, PrendergastBJ. Sex differences in pharmacokinetics predict adverse drug reactions in women. Biol Sex Differ. 2020;11(1):32.
   PubMed Web of Science ®Google Scholar
• Del Rio OlveraFJ, Rodriguez-MoraÁ, Senín-CalderónA, etal. The first session is the one that counts: an exploratory study of therapeutic alliance. Front Psychol. 2022;13:1016963.
   PubMed Web of Science ®Google Scholar
• FinsrudI, Nissen-LieHA, VrabelK, etal. It’s the therapist and the treatment: the structure of common therapeutic relationship factors. Psychother Res. 2022;32:139–150.
   PubMed Web of Science ®Google Scholar
• Eubanks-CarterC, MuranJC, SafranJD. Alliance-focused training. Psychotherapy. 2015;52:69–173.
   Web of Science ®Google Scholar
• KhramtsovaEA, DavisLK, StrangerBE. The role of sex in the genomics of human complex traits. Nat Rev Genet. 2019:20(3):173–190. DOI:10.1038/s41576-018-0083-1
   PubMed Web of Science ®Google Scholar
• ChenC, ZhouJ, XiaY, etal. Ahigher dysregulation burden of brain DNA methylation in female patients implicated in the sex bias of schizophrenia; 2023. DOI:10.21203/rs.3.rs-2496133/v1
   Google Scholar
• McCarthyNS, MeltonPE, CadbyG, etal. Meta-analysis of human methylation data for evidence of sex-specific autosomal patterns. BMC Genomics. 2014;15(1):981. DOI:10.1186/1471-2164-15-981
   PubMedGoogle Scholar
• XiaY, DaiR, WangK, etal. Sex-differential DNA methylation and associated regulation networks in human brain implicated in the sex-biased risks of psychiatric disorders. Mol Psychiatry. 2021:26;835–848. DOI:10.1038/s41380-019-0416-2
   PubMed Web of Science ®Google Scholar
• McCarthyMM, NugentBM, LenzKM. Neuroimmunology and neuroepigenetics in the establishment of sex differences in the brain. Nat Rev Neurosci. 2017:18(8):471–484. DOI:10.1038/nrn.2017.61
   PubMed Web of Science ®Google Scholar
• ZimmermanFJ. Population health science: fulfilling the mission of public health. Milbank Q. 2021:99(1):9–23. DOI:10.1111/1468-0009.12493
   PubMed Web of Science ®Google Scholar
• KniftonL, InglisG. Poverty and mental health: policy, practice and research implications. BJPsych Bull. 2020;44(5):193–196.
   PubMed Web of Science ®Google Scholar
• MallinckrodtB, MilesJR, LevyJJ. The scientist-practitioner-advocate model: addressing contemporary training needs for social justice advocacy. Training Educat Prof Psychol. 2015;8(4):303–311.
   Web of Science ®Google Scholar